Sergio Traversa Relmada Therapeutics, Inc. (RLMD) insider trading activity

RLMD Quotes by TradingView

Sergio Traversa is Chief Executive Officer of RELMADA THERAPEUTICS, INC.. Currently has a direct ownership of 1 Million shares of RLMD, which is worth approximately $2.32 Million. The most recent transaction as insider was on Feb 09, 2021, when has been sold 5,963 shares (Common Stock) at a price of $35.21 per share, resulting in proceeds of $209,957. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1M
36.24% 3M change
160.4% 12M change
Total Value Held $2.32 Million

SERGIO TRAVERSA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2021
SELL
Open market or private sale
$209,957 $35.21 p/Share
5,963 Reduced 6.17%
90,704 Common Stock
Feb 08 2021
SELL
Open market or private sale
$116,054 $35.03 p/Share
3,313 Reduced 3.31%
96,667 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$36,307 $3.24 p/Share
11,206 Added 10.08%
99,980 Common Stock
Feb 03 2021
SELL
Open market or private sale
$3,500 $35.0 p/Share
100 Reduced 0.11%
88,874 Common Stock
Feb 02 2021
SELL
Open market or private sale
$111,484 $35.08 p/Share
3,178 Reduced 3.45%
88,874 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$10,621 $3.24 p/Share
3,278 Added 3.44%
92,052 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$43,030 $3.24 p/Share
13,281 Added 13.01%
88,774 Common Stock
Jan 27 2021
SELL
Open market or private sale
$326,900 $32.69 p/Share
10,000 Reduced 11.7%
75,493 Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$32,400 $3.24 p/Share
10,000 Added 10.47%
85,493 Common Stock
Jan 26 2021
SELL
Open market or private sale
$21,090 $35.15 p/Share
600 Reduced 0.79%
75,493 Common Stock
Jan 25 2021
SELL
Open market or private sale
$45,877 $35.29 p/Share
1,300 Reduced 1.68%
76,093 Common Stock
Jan 22 2021
SELL
Open market or private sale
$77,686 $35.8 p/Share
2,170 Reduced 2.73%
77,393 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$13,187 $3.24 p/Share
4,070 Added 4.87%
79,563 Common Stock
ST

Sergio Traversa

Chief Executive Officer
Coral Gables,, FL

Track Institutional and Insider Activities on RLMD

Follow RELMADA THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLMD shares.

Notify only if

Insider Trading

Get notified when an Relmada Therapeutics, Inc. insider buys or sells RLMD shares.

Notify only if

News

Receive news related to RELMADA THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RLMD